ABBV vs ROL · P/E 81, rev $61.16B vs P/E 41, rev $3.39B
AbbVie Inc (ABBV) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ABBV and ROL stock pages for the full models.
Not investment advice.